Lafora's PME is an autosomal recessive fatal disorder characterized by childhood learning disorder or adolescent stimuli sensitive myoclonic seizures, ataxia and progressive neurologic deterioration. In 1995 we mapped the Lafora gene locus in chromosome 6q24. In 1998 we reported mutations in a novel gene (EPM2A) that encodes a protein (laforin) and, in 2000, proved that laforin is actually a dual specificity protein tyrosine phosphatase (ds-PTP), 38 kDa in size and cytoplasmic in location, associated with polyribosomes. Phenotype-genotype correlations and intracellular targeting with two natural mutants in exon 3 or exon 4 found in adolescent onset epilepsy resulted in ubiquitin positive perinuclear aggregates. Intracellular targeting of natural mutants in exon l, found in childhood learning disorders, did not produce the same results. These results suggest that laforin is involved in translational regulation and that protein misfolding and degradation produce adolescent epilepsy phenotypes caused by missense mutations in exon 3 and 4. How missense mutations in exon 1 produce childhood learning disorder need to be explored further. Now we propose to: (l) Continue phenotype-genotype correlations by (a) contrasting mutations in childhood onset learning disorder against adolescent onset epilepsy in new lafora patients; (b) completing sequence of Laforin promotor regions and comparing transcripts of exon 1 versus exons 2, 3 and 4, (c) analyzing intracellular targeting of missense mutations in exon 1 versus exon 3 and 4, (d) producing homozygous null mutants of exon 1 KO mice models and contrasting their phenotypes with homozygous null mutants of exon 4 KO mice models. (2) Use immunocytochemistry and in situ hybridization for studies of development and functions of Laforin in brains of normal mice and humans and mice and humans with Lafora's PME. (3) Search for the second gene (EPM2B) for Lafora's PME. These advances raise our hopes for developing treatment(s) for this fatal epilepsy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS042376-03
Application #
6663705
Study Section
Special Emphasis Panel (ZRG1-BDCN-5 (01))
Program Officer
Fureman, Brandy E
Project Start
2001-09-24
Project End
2004-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
3
Fiscal Year
2003
Total Cost
$220,500
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jara-Prado, Aurelio; Ochoa, Adriana; Alonso, María Elisa et al. (2014) Late onset Lafora disease and novel EPM2A mutations: breaking paradigms. Epilepsy Res 108:1501-10
Machado-Salas, Jesús; Avila-Costa, María Rosa; Guevara, Patricia et al. (2012) Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice. Exp Neurol 236:131-40
Delgado-Escueta, Antonio V (2012) Lafora progressive myoclonus epilepsy: glycogen storage disease vs neurodegenerative disease. Neurology 79:21-2
Bai, Dongsheng; Bailey, Julia N; Durón, Reyna M et al. (2009) DNA variants in coding region of EFHC1: SNPs do not associate with juvenile myoclonic epilepsy. Epilepsia 50:1184-90
Medina, M T; Suzuki, T; Alonso, M E et al. (2008) Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 70:2137-44
Suzuki, Toshimitsu; Delgado-Escueta, Antonio V; Alonso, Maria E et al. (2006) Mutation analyses of genes on 6p12-p11 in patients with juvenile myoclonic epilepsy. Neurosci Lett 405:126-31
Martinez-Juarez, Iris E; Alonso, Maria Elisa; Medina, Marco T et al. (2006) Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 129:1269-80
de Nijs, Laurence; Lakaye, Bernard; Coumans, Bernard et al. (2006) EFHC1, a protein mutated in juvenile myoclonic epilepsy, associates with the mitotic spindle through its N-terminus. Exp Cell Res 312:2872-9
Ganesh, Subramaniam; Tsurutani, Naomi; Amano, Kenji et al. (2005) Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins. Neurosci Lett 387:62-7
Ganesh, Subramaniam; Tsurutani, Naomi; Suzuki, Toshimitsu et al. (2003) The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain. Hum Mol Genet 12:2359-68

Showing the most recent 10 out of 11 publications